My question:
Hi Sarah,
Why have we still not heard about what the ending eGFR was for patients treated with Apabetalone whose baseline eGFR was under 60, in the BETONMACE trial,...?
Are we still waiting for a publication about it,... ?
Regard
Their answer:
Thank you for your email. We will continue to evaluate all venues and formats for the future release of our sensitive and important data and cannot make specific comments on timing at the current time.
